Triple inhaled therapy - two bronchodilators and a steroid - is believed to be highly effective in the treatment of COPD according to researchers who have been advocating the development of a triple inhaler.
These findings are some of the most interesting results of all as per Study leader Professor Jadwiga Wedzicha, head of respiratory medicine at the Royal Free and University College Medical School in London since all of the concerned drugs have different and possible synergistic clinical activities.
From Pulsetoday.co.uk:
Data from the INSPIRE trial, comparing salmeterol/fluticasone with tiotropium in 1,323 patients with severe COPD found exacerbation rates were similar between the two groups.
But the nature of the exacerbations seemed to differ between the two groups. Patients who suffered an exacerbation while using salmeterol/fluticasone were more likely to need antibiotics while thos eon tiotropium tended to be treated with steroids.
Study leader Professor Jadwiga Wedzicha, head of respiratory medicine at the Royal Free and University College Medical School in London, said: ‘This is possibly the most interesting result of all - that these drugs have different and possibly synergistic clinical activity.’
This study is believed to provide a new paradigm before the medical fraternity when it comes to helping COPD patients and finding effective treatment ways to cure this ailment.
If you would like to make a comment, please fill out the form below.
